MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 290 filers reported holding MIRATI THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.39 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,181,134 | +49.0% | 27,115 | +23.6% | 0.00% | +100.0% |
| Q2 2023 | $792,443 | +1.3% | 21,933 | +4.3% | 0.00% | 0.0% |
| Q1 2023 | $781,942 | -31.7% | 21,031 | -16.7% | 0.00% | -50.0% |
| Q4 2022 | $1,144,050 | +32.9% | 25,249 | +104.7% | 0.00% | +100.0% |
| Q3 2022 | $861,000 | +3.4% | 12,335 | -0.6% | 0.00% | 0.0% |
| Q2 2022 | $833,000 | +57.8% | 12,405 | +93.2% | 0.00% | 0.0% |
| Q1 2022 | $528,000 | +143.3% | 6,422 | +424.7% | 0.00% | – |
| Q3 2021 | $217,000 | -11.1% | 1,224 | +10.2% | 0.00% | – |
| Q4 2020 | $244,000 | -34.9% | 1,111 | -69.4% | 0.00% | -100.0% |
| Q2 2019 | $375,000 | +58.9% | 3,628 | -27.4% | 0.00% | 0.0% |
| Q3 2018 | $236,000 | – | 5,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,135,966 | $136,602,679 | 87.83% |
| EcoR1 Capital, LLC | 5,748,399 | $250,400,260 | 8.45% |
| Boxer Capital, LLC | 3,201,440 | $139,454,726 | 7.42% |
| RTW INVESTMENTS, LP | 6,768,514 | $294,836,470 | 6.22% |
| Paradigm Biocapital Advisors LP | 1,668,116 | $72,663,133 | 4.93% |
| Avoro Capital Advisors LLC | 6,666,666 | $290,399,971 | 4.53% |
| Octagon Capital Advisors LP | 655,051 | $28,534,022 | 4.38% |
| Artal Group S.A. | 2,024,226 | $88,175 | 3.78% |
| Ally Bridge Group (NY) LLC | 70,283 | $3,061,527 | 3.59% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 216,000 | $9,404,640 | 3.17% |